Morningstar analyst Xavier Lee has an unchanged FV of $1.60.
Analysts at Maybank Securities (Maybank), UOB Kay Hian (UOBKH), DBS Group Research (DBS) and OCBC Investment Research (OIR) are all keeping their "buy" calls following Mapletree Pan Asia Commercial Trust's (MPACT) results for the 4QFY2025 ended March 31. Morningstar Equity Research has kept its four-star rating as well.
While Maybank and UOBKH have raised their respective target prices (TP) to $1.30 from $1.20 previously and $1.62 from $1.60 previously, DBS and OIR have conversely lowered their respective TP and fair value (FV) to $1.50 from $1.80 previously and $1.45 from $1.48 previously.
